Welcome to TLV
The Dental and Pharmaceutical Benefits Agency, TLV, is a central government agency whose remit is to determine whether a pharmaceutical product or dental care procedure shall be subsidized by the state. We also have the responsibility for monitoring profitability on the pharmacy market.
In other words, we strive to create the greatest possible improvements in health using the tax revenues that are allocated for medicines and dental care. This responsibility has been assigned to a central government agency to ensure that benefits are equally distributed through Sweden.
When we take a decision on whether a pharmaceutical product or dental care procedure shall be subsidized or not, we consider costeffectiveness, i.e. whether or not the cost of the treatment is reasonable in relation to the good it does.
Based on good principles
Our decisions are also based upon the concept of providing more assistance to those people who have the greatest needs. The equality of all people is the third principle that we base our decisions upon.
The TLV cooperates with patient organisations in a "User Council". In more comprehensive decisions, involved patient organisations may also submit comments.
Publicerad: 3 oktober 2008
Webbansvarig: Gunilla V Johansson
From LFN to TLV
The TLV was previously known as the LFN. The LFN was established in 2002 and was responsible for taking decisions on what prescription-only pharmaceutical products and medical devices would be subsidized.
In July 2008, a new dental care reform went into effect; a new law whose aim is to make it less expensive to go to the dentist, especially for those who are in the greatest need of dental care.
As the new Dental Care Benefits Board was established, on Sept 1, 2008 the name of the LFN was changed to the TLV, the Dental and Pharmaceutical Benefits Agency to better reflect the remit.